Demonstration of an outer membrane protein that is antigenically specific for Acinetobacter baumannii

Diagnostic Microbiology and Infectious Disease

Volumn 69, Issue 1, 2011, Pages 38-44

  Islam, Abul Hasnat Mohammad Shafiqul ^a   Singh, Kirnpal Kaur Banga ^b   Ismail, Asma ^a  

^a INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

^b SCHOOL OF PHYSICS   (Malaysia)

Author keywords

Acinetobacter baumannii; Diagnostic biomarker; Nosocomial infection; Outer membrane protein

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INNER MEMBRANE PROTEIN; MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; WESTERN BLOTTING;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIOLOGICAL TECHNIQUES; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SENSITIVITY AND SPECIFICITY;

EID: 78649969380     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.09.008     Document Type: Article

References (17)

1. Bergogne-Berezin E., Towner K.J. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 1996, 9:148-165.
2. Bernards A.T., Harinck H.I.J., Dijkshoorn L., Reijden T.J.K., Broek P.J. Persistent Acinetobacter baumannii? Look inside your medical equipment. Infect. Control Hosp. Epidemiol. 2004, 25:1002-1004.
3. Centers for Disease Control and Prevention (CDC) Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb. Mortal. Wkly Rep. 2004, 53:1063-1066.
4. Davis K.A., Moran K.A., McAllister C.K., Gray P.J. Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg. Infect. Dis. 2005, 11:1218-1224.
5. Deris Z.Z., Harun A., Shafei M.N., Rahman R.A., Johari M.R. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia. Southeast Asian J. Trop. Med. Public Health 2009, 40:140-147.
6. Ismail A., Hai O.K., Kader Z.A. Demonstration of an antigenic protein specific for Salmonella typhi. Biochem. Biophys. Res. Commun. 1991, 18:301-305.
7. Koulenti D., Rello J. Gram-negative bacterial pneumonia: aetiology and management. Curr. Opin. Pulm. Med. 2006, 12:198-204.
8. Lee S.O., Kim N.J., Choi S.H., Kim T.H., Chung J.W., Woo J.H., Ryu J., Kim Y.S. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob. Agents Chemother. 2004, 48:224-228.
9. Levin A.S., Levy C.E., Manrique A.E.I., Medeiros E.A.S., Costa S.F. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int. J. Antimicrob. Agents 2003, 21:58-62.
10. Noskin G.A. Tigecycline: a new glycylcycline for treatment of serious infections. Clin. Infect. Dis. 2005, 41:303-314.
11. Peleg A.Y., Potoski B.A., Rea R., Adams J., Sethi J., Capitano B., Husain S., Kwak E.J., Bhat S.V., Paterson D.L. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J. Antimicrob. Chemother. 2007, 59:128-131.
12. Playford E.G., Craig J.C., Iredell J.R. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J. Hosp. Infect. 2007, 65:204-211.
13. Scott P., Deve G., Srinivasan A., Murray C., Moran K., Hulten E., Fishbain J., Craft D., Riddell S., Lindler L., Mancuso J., Milstrey E., Bautista C.T., Patel J., Ewell A., Hamilton T., Gaddy C., Tenney M., Christopher G., Petersen K., Endy T., Petruccelli B. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US Military Health Care System associated with military operations in Iraq. Clin. Infect. Dis. 2007, 44:1577-1584.
14. Wisplinghoff H., Schmitt R., Wohrmann A., Stefanik D., Seifert H. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. J. Hosp. Infect. 2007, 66:174-181.
15. Woods C.R. Antimicrobial resistance: mechanisms and strategies. Paediatr. Respir. Rev. 2006, 7:128-129.
16. World Health Organization Prevention of hospital-acquired infection: a practical guide. WHO/CDS/CSR/EPH/2002.12 2002, WHO, Geneva.
17. Zong Z., Lu X., Valenzuela J.K., Partridge S.R., Iredell J. An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China. Int. J. Antimicrob. Agents 2008, 31:50-54.